Advertisement Cobalis signs master broker agreement with Melodic Distribution Company - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cobalis signs master broker agreement with Melodic Distribution Company

Cobalis, a biotechnology company, has entered into a master broker agreement with Melodic Distribution Company. The goal of the agreement is to take advantage of MDC's strong international distribution channels and strategic partners.

Melodic Distribution Company (MDC) will seek international distribution for PreHistin within its network throughout Europe, Australia and Asia. MDC has received very strong indications of interest from its key distribution partners and will look to secure multiple distribution agreements in the near term.

Chas Radovich, CEO of Cobalis, said: “We are very excited to have MDC represent us in the international distribution community. They are well connected in all territories that Cobalis plans to penetrate. This will expedite our ability to launch PreHistin overseas and will coincide with our initial launch first quarter 2009 in the US.”